Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300
The transaction is anticipated to close in the first quarter of 2022
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
Subscribe To Our Newsletter & Stay Updated
